WEBVTT

00:00:00.700 --> 00:00:03.430
You've built a new device or therapy.

00:00:03.430 --> 00:00:06.210
The next milestone is its first human data,

00:00:06.210 --> 00:00:08.990
and investors and the FDA will scrutinize it.

00:00:08.990 --> 00:00:14.130
bioaccess® is the first-in-human CRO for the Americas.

00:00:14.130 --> 00:00:17.380
“Will the FDA accept data from Latin America?”

00:00:17.380 --> 00:00:18.420
It can.

00:00:18.420 --> 00:00:21.160
FDA may accept data from studies run outside

00:00:21.160 --> 00:00:23.520
the U.S. when they follow Good Clinical Practice

00:00:23.520 --> 00:00:26.720
and the agency can validate the data.

00:00:26.720 --> 00:00:27.990
It's decided case by case.

00:00:27.990 --> 00:00:31.880
So we start with your U.S. regulatory strategy,

00:00:31.880 --> 00:00:33.830
often an FDA Pre-Sub,

00:00:33.830 --> 00:00:36.700
and design the study to that standard from day one.

00:00:36.700 --> 00:00:39.100
“Which country is right for my study?”

00:00:39.100 --> 00:00:40.470
We work across Latin America

00:00:40.470 --> 00:00:43.600
and recommend the country that fits your protocol,

00:00:43.600 --> 00:00:45.940
your patients and your milestone.

00:00:45.940 --> 00:00:47.300
There's no default.

00:00:47.300 --> 00:00:49.780
“Do you have the right sites and investigators?”

00:00:50.050 --> 00:00:52.930
“How long will it take, and what will it cost?”

00:00:52.930 --> 00:00:55.650
Both depend on your protocol and country.

00:00:55.650 --> 00:00:56.800
You get a study-specific

00:00:56.800 --> 00:00:59.080
timeline and an itemized budget,

00:00:59.080 --> 00:01:01.140
with pass-through costs agreed line

00:01:01.140 --> 00:01:03.290
by line before the study starts.

00:01:03.290 --> 00:01:04.890
“What do you actually do?”

00:01:04.890 --> 00:01:07.840
We anchor on U.S. regulatory strategy and execute

00:01:07.840 --> 00:01:11.860
on the ground across Latin America: submissions,

00:01:11.860 --> 00:01:14.810
site selection and activation, device import,

00:01:14.810 --> 00:01:16.420
monitoring and data.

00:01:16.760 --> 00:01:18.470
First-in-human work is where

00:01:18.470 --> 00:01:20.310
medical innovation begins.

00:01:20.310 --> 00:01:24.480
See how we approach it at bioaccessla.com,

00:01:24.480 --> 00:01:26.420
and download our corporate deck.

